Is dopamine related to immunologic changes in schizophrenic patients?
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D014150:Antipsychotic Agents; D004298:Dopamine